AR225925A1 - Procedimiento para obtener compuestos de(1,2,3-tiadiazol)-4,5-h)o(5,4-h)-6,7,8,9-tetraisoquinolina y sus sales - Google Patents

Procedimiento para obtener compuestos de(1,2,3-tiadiazol)-4,5-h)o(5,4-h)-6,7,8,9-tetraisoquinolina y sus sales

Info

Publication number
AR225925A1
AR225925A1 AR281587A AR28158780A AR225925A1 AR 225925 A1 AR225925 A1 AR 225925A1 AR 281587 A AR281587 A AR 281587A AR 28158780 A AR28158780 A AR 28158780A AR 225925 A1 AR225925 A1 AR 225925A1
Authority
AR
Argentina
Prior art keywords
tiadiazole
tetraisoquinoline
salts
procedure
obtaining compounds
Prior art date
Application number
AR281587A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Application granted granted Critical
Publication of AR225925A1 publication Critical patent/AR225925A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AR281587A 1979-07-02 1980-06-30 Procedimiento para obtener compuestos de(1,2,3-tiadiazol)-4,5-h)o(5,4-h)-6,7,8,9-tetraisoquinolina y sus sales AR225925A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5434379A 1979-07-02 1979-07-02

Publications (1)

Publication Number Publication Date
AR225925A1 true AR225925A1 (es) 1982-05-14

Family

ID=21990408

Family Applications (1)

Application Number Title Priority Date Filing Date
AR281587A AR225925A1 (es) 1979-07-02 1980-06-30 Procedimiento para obtener compuestos de(1,2,3-tiadiazol)-4,5-h)o(5,4-h)-6,7,8,9-tetraisoquinolina y sus sales

Country Status (30)

Country Link
EP (1) EP0023761B1 (xx)
JP (1) JPS5610192A (xx)
KR (1) KR840000396B1 (xx)
AR (1) AR225925A1 (xx)
AT (1) ATE6515T1 (xx)
AU (1) AU531641B2 (xx)
BG (1) BG51250A3 (xx)
CA (1) CA1129415A (xx)
CS (1) CS215064B2 (xx)
DD (1) DD151750A5 (xx)
DE (1) DE3066826D1 (xx)
DK (1) DK151029C (xx)
ES (1) ES492971A0 (xx)
FI (1) FI67221C (xx)
GR (1) GR69206B (xx)
HU (1) HU179382B (xx)
IE (1) IE50290B1 (xx)
IL (1) IL60426A (xx)
IN (1) IN160542B (xx)
MX (1) MX6317E (xx)
NO (1) NO801951L (xx)
NZ (1) NZ194156A (xx)
PH (1) PH17042A (xx)
PL (2) PL127098B1 (xx)
PT (1) PT71458A (xx)
RO (1) RO79707A (xx)
SU (1) SU1072809A3 (xx)
YU (1) YU171180A (xx)
ZA (1) ZA802987B (xx)
ZW (1) ZW14680A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988339A (en) * 1974-02-08 1976-10-26 Smithkline Corporation Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase
US3939164A (en) * 1974-02-08 1976-02-17 Smithkline Corporation 7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds

Also Published As

Publication number Publication date
IL60426A0 (en) 1980-09-16
CS215064B2 (en) 1982-07-30
IE801352L (en) 1981-01-02
MX6317E (es) 1985-04-01
HU179382B (en) 1982-10-28
IE50290B1 (en) 1986-03-19
SU1072809A3 (ru) 1984-02-07
ES8105736A1 (es) 1981-06-01
ATE6515T1 (de) 1984-03-15
IN160542B (xx) 1987-07-18
FI802112A (fi) 1981-01-03
DE3066826D1 (en) 1984-04-12
PL127098B1 (en) 1983-09-30
DK274280A (da) 1981-01-03
CA1129415A (en) 1982-08-10
BG51250A3 (en) 1993-03-15
FI67221C (fi) 1985-02-11
ZA802987B (en) 1981-05-27
DD151750A5 (de) 1981-11-04
KR830002791A (ko) 1983-05-30
YU171180A (en) 1983-09-30
NZ194156A (en) 1983-03-15
PL230619A1 (xx) 1981-12-11
AU531641B2 (en) 1983-09-01
PL225377A1 (xx) 1981-08-21
ES492971A0 (es) 1981-06-01
EP0023761B1 (en) 1984-03-07
DK151029C (da) 1988-03-07
KR840000396B1 (ko) 1984-03-30
EP0023761A1 (en) 1981-02-11
PH17042A (en) 1984-05-17
NO801951L (no) 1981-01-05
FI67221B (fi) 1984-10-31
GR69206B (xx) 1982-05-07
IL60426A (en) 1984-03-30
RO79707A (ro) 1982-08-17
JPS5610192A (en) 1981-02-02
DK151029B (da) 1987-10-12
PT71458A (en) 1980-07-01
AU5967780A (en) 1981-01-15
ZW14680A1 (en) 1980-09-24

Similar Documents

Publication Publication Date Title
AR240807A1 (es) Procedimiento para obtener derivados de benzazepin-2-ona y sus sales
ES487464A0 (es) Procedimiento de preparacion de nuevos derivados aldehidos peptidil-argininos y de sus sales
AR228444A1 (es) Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales
AR222481A1 (es) Procedimiento para obtener derivados de 1-(omega-alcanoiltio o omega-mercaptoalconoil)3,4-deshidroprolina
ES512067A0 (es) "procedimiento para la preparacion de derivados de eter arilfenilico".
IT8023437A0 (it) Sonda per l'allineamento di fori.
AR224495A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-7,8-dihidroxi o 7,8-dialcanoiloxi-1,3,4,5-tetrahidro-1h-3-benzazepina y sus sales
ES524185A0 (es) Procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina.
AR230059A1 (es) Procedimiento para obtener derivados de piperidil-1-il-alcoxi o hidroxialcoxi-carboestirilo o 3,4-dihidrocarboestirilo
AR228949A1 (es) Procedimiento para la preparacion de nuevos derivados de pirido(1,2-a)pirimidina y sus sales
AR228144A1 (es) Procedimiento para obtener derivados de 5-fenil-triazolidina-2,4-diona y sus sales
AR231638A1 (es) Procedimiento para obtener compuestos de 1-1-2-(1,4-benzoxatio o 1,4-benzoxatian o 1,4-benzodioxan-2-il)-alquilen-4-piperidil-2-imidazolinona,2-hexahidro-pirimidinona o 2-imino-imidazolidina
AR228586A1 (es) Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables
IT1098841B (it) Procedimento e relattivi per l'individuazione di sostanze cancerogene e di sostanze anticancerose
MX155760A (es) Procedimiento para la preparacion de 1-amino-4-hidroxi-2-fenoxiantraquinonas o 1-amino-4-hidroxi-2-alcoxiantraquinonas
AR223160A1 (es) Procedimiento para preparar derivados de 3-aminoalquiltiazolidindiona(2,4)y sus sales
ES515031A0 (es) Procedimiento para la obtencion de derivados de azolil-fenoxisustituidos.
AR231289A1 (es) Procedimiento para preparar derivados de quinolil-4-1-piperidilo-4-2-etanol o quinolil-4-1-piperidil-4-3-propanol
ES495932A0 (es) Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina.
AR222318A1 (es) Procedimiento para la elaboracion de compuestos de 2-carboxi o 2-hidroximetil-benzimidazol y sus sales
AR225925A1 (es) Procedimiento para obtener compuestos de(1,2,3-tiadiazol)-4,5-h)o(5,4-h)-6,7,8,9-tetraisoquinolina y sus sales
AR228437A1 (es) Procedimiento para preparar compuestos de 6-fenil-2-oxo-nicotinoilamoxicilina y sus sales
ES493016A0 (es) Procedimiento para la preparacion de nuevas 2-(perhi- dro-1,4-diazino)-pirimido(5,4-d)pirimidinas
ES519853A0 (es) Un procedimiento para la preparacion de derivados de anilinay sus sales.
AR228039A1 (es) Procedimiento para obtener derivados de 2-(n'-fenilhidrazino)-1-pirrolina y sus sales